NEW YORK--(BUSINESS WIRE)--Munich Re Life US together with the American Cancer Society (ACS) today announced a four-year partnership amplifying both organizations’ commitment to saving more lives from cancer. As part of the partnership, Munich Re and ACS will collaborate on cancer-related research initiatives involving their respective research and medical teams. In addition, Munich Re will partially fund two critical ACS Research Scholar Grants in the aggregate of $250,000 as well as activate employee giving by launching nationwide philanthropic campaigns and volunteer opportunities.
With this partnership, Munich Re becomes the first company in the reinsurance space to support ACS Research Scholar Grants. Recipients are early-stage investigators with innovative ideas that are on the cutting edge of science.
“We are honored to embark upon this journey with a leading advocacy organization making valuable contributions to the field of cancer research,” said Marc-Andre Giguere, President and CEO, US Life and Health, Munich Re Life US. “Cancer mortality is an important area of focus for us and being able to support and develop pioneering ideas to prevent cancer-related deaths, improve quantity and quality of lives and identify treatments that enhance medical outcomes aligns perfectly with our values and mission.”
“To change the future of cancer, we need to continue to invest in the most brilliant young investigators and most innovative cancer research,” explained William Phelps, PhD, Senior Vice President for Extramural Research at the American Cancer Society. “We are pleased to have a partner in Munich Re whose continued support of the Society’s mission will help us make a meaningful difference in every community.”
ACS currently supports research and training grants in a wide range of cancer-related disciplines at 57 institutions across the United States. At any one point in time, the Society directs donated dollars to fund more than 800 grantees throughout the country and across cancer types. Since 1946, ACS has invested more than $4.9 billion including funding 49 researchers who went on to win the Nobel Prize.
About Munich Re Life US
As one of the world’s leading life reinsurers, Munich Re Life US partners with insurance carriers to leverage smart and connected data, embrace new ideas and technologies, help carriers make confident decisions at speed and scale, and gain an exponential understanding of underlying risks. The company is well known in the industry as an innovation leader with extensive technical depth. Munich Re Life US’ optimized solutions and capital management expertise expand beyond market leading offerings in individual life reinsurance, group, individual disability and living benefits, to a global center for predictive analytics, automated underwriting, digital partnerships and standard-setting underwriting and medical capabilities. The company believes that the digital economy offers an unprecedented opportunity for the industry to rapidly advance risk assessment and help close the widening global underinsured gap.
Munich Re Life US, incorporated as Munich American Reassurance Company., is a subsidiary of Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München (“Munich Re”), and earns high ratings for financial strength from A.M. Best Company. Munich Re Life US serves clients throughout the United States from its three locations in New York, Atlanta and Chicago.
About Munich Re
Munich Re is one of the world’s leading providers of reinsurance, primary insurance and insurance-related risk solutions. The group consists of the reinsurance and ERGO business segments, as well as the capital investment company MEAG. Munich Re is globally active and operates in all lines of the insurance business. Its tailor-made solutions and close proximity to its customers make Munich Re one of the world’s most sought-after risk partners for businesses, institutions, and private individuals.
About the American Cancer Society
The American Cancer Society is a global grassroots force of 1.5 million volunteers dedicated to saving lives, celebrating lives, and leading the fight for a world without cancer. From breakthrough research, to free lodging near treatment, a 24/7/365 live helpline, free rides to treatment, and convening powerful activists to create awareness and impact, the Society is attacking cancer from every angle. The Society does not endorse any product or service. For more information go to www.cancer.org